贵阳医学院附属医院王小林案回溯：改制与并购背后的贪腐链条

Group 1 - The case of Wang Xiaolin, former Vice President of Guiyang Medical College and President of its affiliated hospital, resulted in a death sentence with a two-year reprieve for bribery, along with lifelong deprivation of political rights and confiscation of personal assets [1] - The bribery scandal has implicated the A-share listed company Xinbang Pharmaceutical, which acquired 98.25% of Keke Pharmaceutical in 2013, a company formed from the restructuring of the drug sales department of the affiliated hospital [1][2] - Xinbang Pharmaceutical has grown to become a leading pharmaceutical distribution enterprise in Guizhou Province, establishing a comprehensive sales network covering major hospitals in the region [2] Group 2 - Following Wang Xiaolin's downfall, a corruption documentary aired in January 2025, revealing that a pharmaceutical supply company, restructured from the hospital's drug sales department, had terminated a merger with a state-owned enterprise under Wang's influence, leading to a subsequent acquisition by another pharmaceutical company [2]